Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Ching Chang

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Hepato-Gastroenterology|September 24, 2011
The efficacy of chemotherapy in patients with high-grade metastatic colon cancerChia-Jen Liu, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease|July 19, 2022
Clinical outcome of local treatment and radical resection for pT1 rectal cancerSummer Sheue-Tsuey Pai, Hung-Hsin Lin, Hou-Hsuan Cheng, et al.
International Journal of Colorectal Disease|May 23, 2013
Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasisYen-Chen Shao, Yu-Yao Chang, Jen-Kou Lin, et al.
International Journal of Molecular Sciences|July 2, 2021
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal CancerHung-Ming Chen, Chun-Chi Lin, Wei-Shone Chen, et al.
British Journal of Cancer|June 30, 2021
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colonKun-Han Lee, Wei-Shone Chen, Jeng-Kai Jiang, et al.
The Oncologist|July 12, 2019
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal CancerMing-Huang Chen, Shih-Ching Chang, Pei-Ching Lin, et al.
American Journal of Clinical Oncology|November 7, 2019
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal CancerCheng-Chun Tai, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Oncotarget|December 25, 2015
Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancersWen-Liang Fang, Kuo-Hung Huang, Yuan-Tzu Lan, et al.
Biochemical and Biophysical Research Communications|May 20, 2009
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancerYu-Chih Chen, Yi-Wei Chen, Han-Shui Hsu, et al.
International Journal of Medical Informatics|March 18, 2026
Automated Flow and local LLM-Driven clinical Context Engineering: Precision colorectal cancer recurrence registryYi-Wen Yang, Che-Yuan Chang, Yu-Zu Lin, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Hepato-Gastroenterology|September 24, 2011
The efficacy of chemotherapy in patients with high-grade metastatic colon cancerChia-Jen Liu, Jen-Kou Lin, Wei-Shone Chen, et al.
International Journal of Colorectal Disease|July 19, 2022
Clinical outcome of local treatment and radical resection for pT1 rectal cancerSummer Sheue-Tsuey Pai, Hung-Hsin Lin, Hou-Hsuan Cheng, et al.
International Journal of Colorectal Disease|May 23, 2013
Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasisYen-Chen Shao, Yu-Yao Chang, Jen-Kou Lin, et al.
International Journal of Molecular Sciences|July 2, 2021
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal CancerHung-Ming Chen, Chun-Chi Lin, Wei-Shone Chen, et al.
British Journal of Cancer|June 30, 2021
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colonKun-Han Lee, Wei-Shone Chen, Jeng-Kai Jiang, et al.
The Oncologist|July 12, 2019
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal CancerMing-Huang Chen, Shih-Ching Chang, Pei-Ching Lin, et al.
American Journal of Clinical Oncology|November 7, 2019
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal CancerCheng-Chun Tai, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Oncotarget|December 25, 2015
Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancersWen-Liang Fang, Kuo-Hung Huang, Yuan-Tzu Lan, et al.
Biochemical and Biophysical Research Communications|May 20, 2009
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancerYu-Chih Chen, Yi-Wei Chen, Han-Shui Hsu, et al.
International Journal of Medical Informatics|March 18, 2026
Automated Flow and local LLM-Driven clinical Context Engineering: Precision colorectal cancer recurrence registryYi-Wen Yang, Che-Yuan Chang, Yu-Zu Lin, et al.
Pageof 16